METAPLASTIC CARCINOMA OF BREAST: A CASE REPORT

被引:0
作者
Devi, Prema E. [1 ]
Susruthan, M. [1 ]
Narayanan, C. D. [2 ]
Priyathershini, N. [1 ]
Thanka, J. [1 ]
机构
[1] Sri Ramachandra Univ, Dept Pathol, Madras, Tamil Nadu, India
[2] Sri Ramachandra Univ, Dept Surg, Madras, Tamil Nadu, India
来源
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS | 2015年 / 4卷 / 23期
关键词
Breast; Metaplastic carcinoma; Chondrosarcomatous differentiation;
D O I
10.14260/jemds/2015/585
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: Metaplastic carcinomas of the breast comprise less than 1% of all invasive carcinomas. They are a heterogeneous group of malignant breast tumors in which a part or all of carcinomatous epithelium gets converted into a non-glandular (Metaplastic) growth process. 1 The sarcomatoid element can be bone, cartilage spindle cell component or myxoid changes. 2 Here, we report a case of metaplastic carcinoma with chondrosarcomatous differentiation which is even more rarer. CASE PRESENTATION: A 48yrs old female had swelling in the left breast for 2months duration. Fine needle aspiration cytology was done for the swelling (M) 6x5x4cm. An impression of atypical cells seen in cytology was given (Image 1). A modified radical mastectomy was done which showed aninfiltrating carcinoma mixed with heterologous mesenchymal elements which showed areas of cartilage differentiation. A final impression of pT3pN0cM0 nottinghams grade 3 metaplastic carcinoma with chondrosarcomatous differentiation, margins free of tumor was given. DISCUSSION: Metaplastic carcinomas of the breast comprise less than 1% of all invasive carcinomas. They are a heterogeneous group of malignant breast tumors in which a part or all of carcinomatous epithelium gets converted into a nonglandular (Metaplastic) growth process. 1This case is presented here due to its rarity and hence reporting this will help surgeons in diagnosis.
引用
收藏
页码:4052 / 4057
页数:6
相关论文
共 15 条
[1]   Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression [J].
Barnes, PJ ;
Boutilier, R ;
Chiasson, D ;
Rayson, D .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 91 (02) :173-178
[2]  
Dewasi N, 2014, J PATHOLOGY NEPAL J PATHOLOGY NEPAL, V4, P594
[3]   Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast [J].
Hayes, Michael J. ;
Thomas, Dafydd ;
Emmons, Agnieszka ;
Giordano, Thomas J. ;
Kleer, Celina G. .
CLINICAL CANCER RESEARCH, 2008, 14 (13) :4038-4044
[4]  
IsilGunhan Bilgen, 2002, AM J RES, V178, P1421
[5]   Metaplastic carcinoma with extensive chondroid differentiation in the breast (Chondroid carcinoma) [J].
Kim, Yee-Jeong ;
Shim, Hyo-Seob ;
Lee, Hyde ;
Jung, Woo-Hee .
YONSEI MEDICAL JOURNAL, 2006, 47 (02) :259-263
[6]   Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? [J].
Leibl, S ;
Moinfar, F .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (07) :700-704
[7]   Molecular portraits of human breast tumours [J].
Perou, CM ;
Sorlie, T ;
Eisen, MB ;
van de Rijn, M ;
Jeffrey, SS ;
Rees, CA ;
Pollack, JR ;
Ross, DT ;
Johnsen, H ;
Akslen, LA ;
Fluge, O ;
Pergamenschikov, A ;
Williams, C ;
Zhu, SX ;
Lonning, PE ;
Borresen-Dale, AL ;
Brown, PO ;
Botstein, D .
NATURE, 2000, 406 (6797) :747-752
[8]   Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas [J].
Popnikolov, NK ;
Ayala, AG ;
Graves, K ;
Gatalica, Z .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (02) :161-167
[9]   Metaplastic breast carcinomas are basal-like tumours [J].
Reis-Filho, J. S. ;
Milanezi, F. ;
Steele, D. ;
Savage, K. ;
Simpson, P. T. ;
Nesland, J. M. ;
Pereira, E. M. ;
Lakhani, S. R. ;
Schmitt, F. C. .
HISTOPATHOLOGY, 2006, 49 (01) :10-21
[10]   Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J].
Rouzier, R ;
Perou, CM ;
Symmans, WF ;
Ibrahim, N ;
Cristofanilli, M ;
Anderson, K ;
Hess, KR ;
Stec, J ;
Ayers, M ;
Wagner, P ;
Morandi, P ;
Fan, C ;
Rabiul, I ;
Ross, JS ;
Hortobagyi, GN ;
Pusztai, L .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :5678-5685